Pomdoctor Targets Predictive Healthcare With AI and Wearables
Guangzhou – October 12, 2026 -- Nasdaq-listed Pomdoctor Limited (POM) said it will integrate AI, wearable devices, remote patient monitoring (RPM) and real-world healthcare data with its existing physician resources, aiming to move care from "diagnose and treat" to "predict, alert and intervene."
Pomdoctor bets on chronic disease management as the first use case
The company said continuous monitoring and timely intervention are particularly relevant to chronic disease management. Wearables and RPM can collect health indicators outside clinical settings, while longitudinal and real-world data give a broader view of changes in an individual's health status. AI would analyze these datasets, flag potential risk signals and support earlier healthcare decisions.